✦ LIBER ✦

The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study

✍ Scribed by Gottlieb, Alice B.; Kalb, Robert E.; Blauvelt, Andrew; Heffernan, Michael P.; Sofen, Howard L.; Ferris, Laura Korb; Kerdel, Francisco A.; Calabro, Stephen; Wang, Jim; Kerkmann, Urs; Chevrier, Marc

Book ID: 119263153
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 430 KB
Volume: 67
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2011.10.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept

✍ Robert Bissonnette; Chantal Bolduc; Yves Poulin; Lyn Guenther; Charles W. Lynde; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with plaque psoriasis who failed to show a satisfactory response to etanercept

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Switching to adalimumab for psoriasis pa

Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study

✍ Bruce E. Strober; Yves Poulin; Francisco A. Kerdel; Richard G. Langley; Yihua Gu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 754 KB

Efficacy and safety of infliximab vs. me

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

✍ J. Barker; M. Hoffmann; G. Wozel; J.-P. Ortonne; H. Zheng; H. van Hoogstraten; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Efficacy and safety of adalimumab in a 1

Efficacy and safety of adalimumab in a 120-week open-label extension study in patients with moderate to severe chronic plaque psoriasis

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Efficacy and safety of etanercept 50 mg

Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: Results of a multicenter, randomized, double-blind, active drug–controlled study

✍ Michael E. Weinblatt; Michael H. Schiff; Eric M. Ruderman; Clifton O. Bingham II 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 3 views